A specific laboratory test for the diagnosis of melancholia. Standardization, validation, and clinical utility - PubMed (original) (raw)

doi: 10.1001/archpsyc.1981.01780260017001.

M Feinberg, J F Greden, J Tarika, A A Albala, R F Haskett, N M James, Z Kronfol, N Lohr, M Steiner, J P de Vigne, E Young

PMID: 7458567
DOI: 10.1001/archpsyc.1981.01780260017001

A specific laboratory test for the diagnosis of melancholia. Standardization, validation, and clinical utility

B J Carroll et al. Arch Gen Psychiatry. 1981 Jan.

Abstract

Four hundred thirty-eight subjects underwent an overnight dexamethasone suppression test (DST) to standardize the test for the diagnosis of melancholia (endogenous depression). Abnormal plasma cortisol concentrations within 24 hours after dexamethasone administration occurred almost exclusively in melancholic patients. The best plasma cortisol criterion concentration, above which a DST result may be considered abnormal, was 5 microgram/dL. The optimal dose of dexamethasone was 1 rather than 2 mg. Two blood samples obtained at 4 and 11 PM after dexamethasone administration detected 98% of the abnormal test results. This version of the DST identified melancholic patients with a sensitivity of 67% and a specificity of 96%. Baseline nocturnal plasma cortisol concentrations were not useful. Abnormal DST results were found with similar frequency among outpatients and inpatients with melancholia; but they were not related to age, sex, recent use of psychotropic drugs, or severity of depressive symptoms. Extensive evidence validates this practical test for the diagnosis of melancholia.

PubMed Disclaimer

Cited by

Vasopressin V1B Receptor Antagonists as Potential Antidepressants.
Chaki S. Chaki S. Int J Neuropsychopharmacol. 2021 Jul 14;24(6):450-463. doi: 10.1093/ijnp/pyab013. Int J Neuropsychopharmacol. 2021. PMID: 33733667 Free PMC article. Review.
Urinary 3-methoxy, 4-hydroxyphenylethylene glycol and therapeutic response to maprotiline and indalpine in major depression.
Loo H, Benkelfat C, Vanelle JM, Dennis T, Poirier MF, Olie JP, Scatton B. Loo H, et al. J Neural Transm. 1986;66(1):47-58. doi: 10.1007/BF01262957. J Neural Transm. 1986. PMID: 3734775 Clinical Trial.
Nocturnal melatonin and cortisol secretion in newly admitted psychiatric inpatients. Implications for affective disorders.
Steiner M, Brown GM, Goldman S. Steiner M, et al. Eur Arch Psychiatry Clin Neurosci. 1990;240(1):21-7. doi: 10.1007/BF02190088. Eur Arch Psychiatry Clin Neurosci. 1990. PMID: 2147898
Discovery of blood transcriptomic markers for depression in animal models and pilot validation in subjects with early-onset major depression.
Pajer K, Andrus BM, Gardner W, Lourie A, Strange B, Campo J, Bridge J, Blizinsky K, Dennis K, Vedell P, Churchill GA, Redei EE. Pajer K, et al. Transl Psychiatry. 2012 Apr 17;2(4):e101. doi: 10.1038/tp.2012.26. Transl Psychiatry. 2012. PMID: 22832901 Free PMC article.
The dexamethasone suppression test as a variable in clinical diagnosis and research: a review.
Oei TI. Oei TI. J R Soc Med. 1988 Jan;81(1):31-3. doi: 10.1177/014107688808100114. J R Soc Med. 1988. PMID: 3278116 Free PMC article. Review. No abstract available.

A specific laboratory test for the diagnosis of melancholia. Standardization, validation, and clinical utility - PubMed (original) (raw)